PURPOSE: To determine the long-term performance of the Artisan phakic intraocular lens (PIOL) for the correction of myopia. DESIGN: Long-term (10 years) retrospective follow-up study. PARTICIPANTS: Eighty-nine eyes of 49 patients who underwent Artisan PIOL implantation for the correction of myopia. METHODS: Comparisons were made between preoperative clinical data and the clinical data at 1, 6, and 10 years after surgery. MAIN OUTCOME MEASURES: Refractive stability, refractive predictability, safety, efficacy, best-corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), intraocular pressure, intraoperative problems, corneal endothelial cell density, corneal endothelial cell loss, and glare levels were evaluated. RESULTS: The mean spherical equivalent (SE) after 10 years was -0.70+/-1.00 diopters (D; range, -4.00 to 2.00 D), with no significant change in mean SE between 1, 6, and 10 years. At 10 years, 68.8% of all eyes were within 1.0 D of the intended correction. At 10 years, 31.2% (n = 24) gained 1 or more Snellen lines of BCVA and 2.6% (n = 2) lost more than 2 Snellen lines of BCVA; 93.3% reached a BCVA of 20/40 or better, and 82.0% reached a UCVA of 20/40 or better. The mean intraocular pressure remained stable and was 15.5+/-3.5 mmHg (range, 7-25 mmHg) at 10 years. The mean endothelial cell loss was -8.86+/-16.01% (range, -51.69% to 34.43%) at 10 years. CONCLUSIONS: Long-term results demonstrate that the implantation of an Artisan PIOL for the correction of moderate to high myopia is a stable, predictable, and safe method when strict inclusion criteria for surgery are applied. There was no significant loss of corneal endothelial cells and no reports of long-term glare.
PURPOSE: To determine the long-term performance of the Artisan phakic intraocular lens (PIOL) for the correction of myopia. DESIGN: Long-term (10 years) retrospective follow-up study. PARTICIPANTS: Eighty-nine eyes of 49patients who underwent Artisan PIOL implantation for the correction of myopia. METHODS: Comparisons were made between preoperative clinical data and the clinical data at 1, 6, and 10 years after surgery. MAIN OUTCOME MEASURES: Refractive stability, refractive predictability, safety, efficacy, best-corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), intraocular pressure, intraoperative problems, corneal endothelial cell density, corneal endothelial cell loss, and glare levels were evaluated. RESULTS: The mean spherical equivalent (SE) after 10 years was -0.70+/-1.00 diopters (D; range, -4.00 to 2.00 D), with no significant change in mean SE between 1, 6, and 10 years. At 10 years, 68.8% of all eyes were within 1.0 D of the intended correction. At 10 years, 31.2% (n = 24) gained 1 or more Snellen lines of BCVA and 2.6% (n = 2) lost more than 2 Snellen lines of BCVA; 93.3% reached a BCVA of 20/40 or better, and 82.0% reached a UCVA of 20/40 or better. The mean intraocular pressure remained stable and was 15.5+/-3.5 mmHg (range, 7-25 mmHg) at 10 years. The mean endothelial cell loss was -8.86+/-16.01% (range, -51.69% to 34.43%) at 10 years. CONCLUSIONS: Long-term results demonstrate that the implantation of an Artisan PIOL for the correction of moderate to high myopia is a stable, predictable, and safe method when strict inclusion criteria for surgery are applied. There was no significant loss of corneal endothelial cells and no reports of long-term glare.
Authors: Virgilio Galvis; John F Villamil; María Fernanda Acuña; Paul A Camacho; Jesús Merayo-Lloves; Alejandro Tello; Sandra Lizeth Zambrano; Juan José Rey; Juan Vicente Espinoza; Angélica María Prada Journal: Graefes Arch Clin Exp Ophthalmol Date: 2019-10-28 Impact factor: 3.117
Authors: Muriël Doors; Lars P J Cruysberg; Tos T J M Berendschot; John de Brabander; Frenne Verbakel; Carroll A B Webers; Rudy M M A Nuijts Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-04-30 Impact factor: 3.117